Brief: Castle Biosciences Raises 2022 Revenue Guidance To $130-135 Mln From $118-123 Mln

Castle Biosciences

08/08/2022 22:11

Aug 8 (Reuters) - Castle Biosciences Inc  CSTL.O :
    * CASTLE BIOSCIENCES REPORTS SECOND QUARTER 2022 RESULTS
    * RAISING 2022 REVENUE GUIDANCE TO $130-135 MILLION FROM
$118-123
MILLION
    * Q2 2022 REVENUE INCREASED 53% OVER Q2 2021 TO $34.8
MILLION
    * QTRLY LOSS PER SHARE $0.06
    * Q2 EARNINGS PER SHARE VIEW $-0.76, REVENUE VIEW $28.4
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw6yRx5Ja 
Further company coverage:  CSTL.O 

 ((Reuters.Briefs@thomsonreuters.com;))